Ventas Patents – Key Insights and Stats

Ventas has a total of 32 patents globally, out of which 12 have been granted. Of these 32 patents, 38% patents are active. United States of America is where Ventas has filed the maximum number of patents, followed by Czech Republic and China, it has generated an annual revenue of $3.828 billion in the year 2021. Parallelly, United States of America seems to be the main focused R&D center of Ventas.

Ventas was founded in the year 1998 by Bruce Lunsford. Company is doing business in healthcare and real estate. As of April 2022, Ventas has a market cap of $24.99 Billion.

Do read about some of the most popular patents of Ventas which have been covered by us in this article and also you can find Ventas patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ventas patent portfolio.

How many patents does the founder and the CEO of Ventas have?

The founder, Bruce Lunsford has 0 patents respectively. The CEO, Debra A. Cafaro has 0 patents.

How many patents does Ventas have?

Ventas has a total of 32 patents globally. These patents belong to 21 unique patent families. Out of 32 patents, 13 patents are active.

How Many Patents did Ventas File Every Year?

Ventas Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 132 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVentas Applications FiledVentas Patents Granted
20114
2012
201311
20141
20151
201612
20174
20181
201941
202021
20211
20221

How many Ventas patents are Alive/Dead?

Worldwide Patents

Ventas Patents Portfolio

Patent Families

Ventas Patents

How Many Patents did Ventas File in Different Countries?

Ventas Worldwide Patent filing

Countries in which Ventas Filed Patents

CountryPatents
United States Of America17
Czech Republic3
China2
Europe2
Hong Kong (S.A.R.)2
Israel1
Japan1
India1

Where are Research Centers of Ventas Patents Located?

Research Centers of Ventas Patents

List of Ventas Patents

Ventas PatentsTitle
US11273137B2Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene
US20200405989A1Liquid removal apparatus for a breathing circuit and related method of use
US10772782B2Dynamic tensioning orthosis and related method of use
US20200100970A1Patient Slider Device
US20200100890A1Bone anchor
US10398613B2Patient support device and related method of use
US9981101B2Medical tube holder and related methods
US20160271321A1Directional sheath and related method of use
US9327099B2Medical tube harness
USD746979S1Irrigation, debridement and cleaning basin
US8366612B2Laryngoscope guide and related method of use
US20110253139A1Inhaler module and related system
US20110225726A1Irrigation, debridement and cleaning basin
US20110225661A1Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
US20110082191A1Method for treating or preventing radiation damage by in vivo gene therapy
US20110077466A1Laryngoscope guide and related method of use
USD621927S1Irrigation, debridement and cleaning basin
EP2307542A1Method for treating or preventing radiation damage by in VIVO gene therapy
EP2300607A2Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
CN113366534AMethod for automatically segmenting teeth
CN109154525AIllumination device for an apparatus for establishing the color of a tooth, apparatus for establishing the color of a tooth, comprising said illumination device
WO2019245756A1Resident community management system
WO2011130583A3Inhaler module and related system
WO2011038126A1Laryngoscope guide and related method of use
WO2010033285A3Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
WO2009158563A1Method for treating or preventing radiation damage by in VIVO gene therapy
JP6867399B2Lighting device for teeth color tone determination device, color tone determination device for built-in lighting device
HK1151316AMethod for treating and preventing radiation damage using genetically modified mesenchymal stem cells
HK1151311AMethod for treating or preventing radiation damage by in vivo gene therapy
IL210237AMethod for treating and preventing radiation damage using genetically modified mesenchymal stem cells
IN4917KOLNP2010AMethod for treating and preventing radiation damage using genetically modified mesenchymal stem cells
CZ333340001SFabric
CZ333330001SFabric
CZ328770001SPatterned textile goods

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.